Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients
| dc.contributor.author | Jacobs, G.A. | |
| dc.contributor.author | Gerber, M. | |
| dc.contributor.author | Malan, M.M. | |
| dc.contributor.author | Du Preez, J. | |
| dc.contributor.author | Du Plessis, J. | |
| dc.contributor.researchID | 11329025 - Gerber, Minja | |
| dc.contributor.researchID | 10187243 - Malan, Maides Maria | |
| dc.contributor.researchID | 10065318 - Du Plessis, Jeanetta | |
| dc.contributor.researchID | 10060510 - Du Preez, Jan Lourens | |
| dc.date.accessioned | 2016-01-26T08:51:57Z | |
| dc.date.available | 2016-01-26T08:51:57Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Due to their compromised immune systems, HIV/ AIDS- infected individuals are more susceptible to skin infections. Since fungal and viral cutaneous manifestations are frequently encountered in combination in HIV/AIDS patients, it is appropriate to formulate a topical product containing both ketoconazole (antifungal) and aciclovir (antiviral) | |
| dc.identifier.citation | Jacobs, G.A. et al. 2010. Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients. (In Perspectives in percutaneous penetration, 12th International Conference, 7-10 April, 2010, La Grande Motte, France). Journal of pharmacy and pharmacology, 62(6):789. [https://doi.org/10.1211/jpp.62.06.0016] | en_US |
| dc.identifier.issn | 0022-3573 | |
| dc.identifier.issn | 2042-7158 (Online) | |
| dc.identifier.uri | http://hdl.handle.net/10394/16030 | |
| dc.identifier.uri | https://onlinelibrary.wiley.com/doi/abs/10.1211/jpp.62.06.0016 | |
| dc.identifier.uri | https://doi.org/10.1211/jpp.62.06.0016 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.title | Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients | en_US |
| dc.type | Presentation | en_US |